Fig. 3From: Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysisSummary overall response rate for different treatment combination. Summary overall response rate for single PD-1/PD-L1 inhibitors (A), PD-1/PD-L1 inhibitors combined with chemotherapy (B), PD-1/PD-L1 inhibitors combined with antiangiogenic therapy (C), and PD-1/PD-L1 inhibitors combined with PARP inhibitors (D)Back to article page